Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization
Clinical trial NCT02726074 · COMPLETED
Trial details
- NCT number
- NCT02726074
- Sponsor
- Eisai Korea Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-03
- Primary completion
- 2018-04-26
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.